Japan, March 3 -- BIOCRYST PHARMACEUTICALS INC has got intellectual property rights for 'HUMAN PLASMA KALLIKREIN INHIBITORS.' Other related details are as follows:
Application Number: JP,2021-116716
Category (FI): C07D231/14,C07D231/56@F,C07D401/04,C07D401/12,C07D401/14,C07D403/04,C07D403/12,C07D405/04,C07D405/12,C07D409/04,C07D413/04,C07D417/04,C07D417/12
Stage: Grant (IP right granted following substantive examination.)
Filing Date: July 14, 2021
Publication Date: Oct. 28, 2021
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
